semaglutide
Semaglutide vs Tirzepatide: Obesity Treatment Wins?
Semaglutide vs Tirzepatide: Obesity Treatment Wins? In a 2025 head-to-head trial, tirzepatide produced a 2.6% greater weight loss than semaglutide in women over 50, making it the stronger contender for maximal fat loss. Both drugs are GLP-1 based, yet their mechanisms, dosing schedules, and bone-health profiles differ enough to